Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of GSK Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342 Against TB Disease, in Adults Living in a TB Endemic Region

NCT01755598 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01755598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01755598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of GSK Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342 Against TB Disease, in Adults Living in a TB Endemic Region
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
August 19, 2014
Completion date
November 16, 2018
Enrollment
3,575 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis, tuberculosis vaccines